These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Targeting the cysteine biosynthesis pathway in microorganisms: Mechanism, structure, and drug discovery. Tao Y; Zheng D; Zou W; Guo T; Liao G; Zhou W Eur J Med Chem; 2024 May; 271():116461. PubMed ID: 38691891 [TBL] [Abstract][Full Text] [Related]
43. DNA as a target for antimicrobials. Bolhuis A; Aldrich-Wright JR Bioorg Chem; 2014 Aug; 55():51-9. PubMed ID: 24745376 [TBL] [Abstract][Full Text] [Related]
44. Recent advances in targeting coenzyme A biosynthesis and utilization for antimicrobial drug development. Moolman WJ; de Villiers M; Strauss E Biochem Soc Trans; 2014 Aug; 42(4):1080-6. PubMed ID: 25110006 [TBL] [Abstract][Full Text] [Related]
45. The impact of genomics on discovering drugs against infectious diseases. Boshoff HI; Manjunatha UH Microbes Infect; 2006 May; 8(6):1654-61. PubMed ID: 16690340 [TBL] [Abstract][Full Text] [Related]
46. Analysis of drug binding pockets and repurposing opportunities for twelve essential enzymes of ESKAPE pathogens. Naz S; Ngo T; Farooq U; Abagyan R PeerJ; 2017; 5():e3765. PubMed ID: 28948099 [TBL] [Abstract][Full Text] [Related]
47. Microbial protein targets: towards understanding and intervention. Denny PW Parasitology; 2018 Feb; 145(2):111-115. PubMed ID: 29143719 [TBL] [Abstract][Full Text] [Related]
48. The need to redefine antimicrobial drug discovery. Mylonakis E Curr Pharm Des; 2011; 17(13):1223-4. PubMed ID: 21470109 [No Abstract] [Full Text] [Related]
49. From an evolutionary perspective, all 'new' antimicrobial targets are old: time to think outside the box. Martin JH; Ferro A Br J Clin Pharmacol; 2015 Feb; 79(2):165-7. PubMed ID: 25601036 [No Abstract] [Full Text] [Related]
50. Fragment-Based Phenotypic Lead Discovery To Identify New Drug Seeds That Target Infectious Diseases. Ayotte Y; Bernet E; Bilodeau F; Cimino M; Gagnon D; Lebughe M; Mistretta M; Ogadinma P; Ouali SL; Sow AA; Chatel-Chaix L; Descoteaux A; Manina G; Richard D; Veyrier F; LaPlante SR ACS Chem Biol; 2021 Nov; 16(11):2158-2163. PubMed ID: 34699722 [TBL] [Abstract][Full Text] [Related]
51. Editorial: novel strategies for the design of therapeutic antimicrobial peptides. Boix E Curr Drug Targets; 2012 Aug; 13(9):1119-20. PubMed ID: 22664070 [No Abstract] [Full Text] [Related]
52. The role of genomics in antimicrobial discovery. Mills SD J Antimicrob Chemother; 2003 Apr; 51(4):749-52. PubMed ID: 12654742 [No Abstract] [Full Text] [Related]
53. Systems biology and its impact on anti-infective drug development. Stumpf MP; Robertson BD; Duncan K; Young DB Prog Drug Res; 2007; 64():1, 3-20. PubMed ID: 17195469 [TBL] [Abstract][Full Text] [Related]
54. The medicinal chemistry of anti-infectious agents. González-Bello C Curr Top Med Chem; 2008; 8(7):532. PubMed ID: 18473881 [No Abstract] [Full Text] [Related]
55. Anti-trypanosomatid drug discovery: an ongoing challenge and a continuing need. Field MC; Horn D; Fairlamb AH; Ferguson MAJ; Gray DW; Read KD; De Rycker M; Torrie LS; Wyatt PG; Wyllie S; Gilbert IH Nat Rev Microbiol; 2017 Jul; 15(7):447. PubMed ID: 28579611 [No Abstract] [Full Text] [Related]
56. Author Correction: Anti-trypanosomatid drug discovery: progress and challenges. De Rycker M; Wyllie S; Horn D; Read KD; Gilbert IH Nat Rev Microbiol; 2022 Nov; 20(11):702. PubMed ID: 36100771 [No Abstract] [Full Text] [Related]
57. The structure of lipopolysaccharide transport protein B (LptB) from Burkholderia pseudomallei. Pankov G; Dawson A; Hunter WN Acta Crystallogr F Struct Biol Commun; 2019 Apr; 75(Pt 4):227-232. PubMed ID: 30950822 [TBL] [Abstract][Full Text] [Related]